Early Gestational Diabetes Mellitus: An Update.

Area of Science:

• Obstetrics and Gynecology
• Endocrinology
• Public Health

Background:

• Hyperglycemia in pregnancy, including gestational diabetes mellitus (GDM), is a significant global health concern.
• Current guidelines recommend GDM screening during pregnancy, with a shift towards earlier detection in the first trimester.
• GDM is classified as conventional (cGDM, 24-28 weeks) or early (eGDM, <20 weeks), with evolving evidence on eGDM management.

Purpose of the Study:

• To review the current understanding and evidence regarding the diagnosis and management of early gestational diabetes mellitus (eGDM).
• To highlight the findings of the Treatment of Booking Gestational Diabetes Mellitus (ToBOGM) study concerning eGDM.
• To emphasize the importance of early GDM screening and treatment in high-burden populations like India.

Main Methods:

• Review of existing literature and evidence on eGDM.
• Analysis of the randomized control trial, Treatment of Booking Gestational Diabetes Mellitus (ToBOGM) study.
• Discussion of screening timing and glucose level thresholds for optimal eGDM detection.

Main Results:

• The ToBOGM study demonstrated clear benefits in diagnosing and treating eGDM.
• Optimal outcomes were observed in women screened before 14 weeks of gestation.
• Specific glucose level ranges (FPG 95-109 mg/dL, 1-hour >191 mg/dL, 2-hour 162-199 mg/dL) indicated better results.

Conclusions:

• Diagnosing and treating eGDM is beneficial and safe, supported by recent trial evidence.
• Screening for GDM at the first antenatal booking visit is crucial for early detection.
• Timely intervention for eGDM is essential, particularly in regions with a high prevalence of hyperglycemia in pregnancy.